IR
Superintel
Overview
Markets
Watchlist
More
Turning Point Therapeutics I
CUSIP: 90041T958 | 5 institutional holders
Watch
Quarters
Q2 2022
Q1 2022
Q4 2021
Q3 2021
Q2 2021
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile